Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 219-101-8 | CAS number: 2359-11-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Aug 30, 1995 to October 27, 1995
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 995
- Report date:
- 1955
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 1-oxa-4-azaspiro[4.5]decan-4-ethanol
- EC Number:
- 219-101-8
- EC Name:
- 1-oxa-4-azaspiro[4.5]decan-4-ethanol
- Cas Number:
- 2359-11-7
- Molecular formula:
- C10H19NO2
- IUPAC Name:
- 2-{1-oxa-4-azaspiro[4.5]decan-4-yl}ethan-1-ol
- Test material form:
- gas under pressure: refrigerated liquefied gas
- Details on test material:
- Identification: HEOX-CN
Chemical Name: 1-0xa-4-azaspiro[4.5]decane-4-ethanol
Cas-number : 2359-11-7
Description Clear liquid at 30°C
Batch: 0029504011005
Purity: (purity: 98.9+/- 0.4 % m/m; cyclohexanone: 0.50 +/- 0.15% m/m;
diethanolamine: 0.15 +/- 0.10 % m/m)
Test substance storage: In refrigerator, dry and in the dark
Stability under storage
conditions: Stable
Expiry date: December 01, 1995
Density: 1050 kg/m3 (40°C)
Preparation The test substance was dosed undiluted as delivered by the sponsor
Stability in vehicle Dimethylsulphoxide; not indicated
Constituent 1
Method
- Target gene:
- Histidine operon for Salmonella
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Details on mammalian cell type (if applicable):
- Not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 fraction was obtained from livers of rats treated with Aroclor 1254 (500 mg/kg body weight) in corn oil
- Test concentrations with justification for top dose:
- Expt 1: 3, 10, 33, 100, 333, 1000, 3330, and 5000 ug/plate.
Expt 2: 100, 333, 1000, 3330, and 5000 ug/plate. - Vehicle / solvent:
- dimethylsulphoxide
Controlsopen allclose all
- Untreated negative controls:
- yes
- Remarks:
- test item in dimethylsulphoxide
- Positive controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- Remarks:
- described under test system conditions
- Positive control substance:
- 9-aminoacridine
- Remarks:
- described under test system conditions
- Positive control substance:
- methylmethanesulfonate
- Remarks:
- described under test system conditions
- Positive control substance:
- other: 2-aminoanthracene
- Remarks:
- described under test system conditions
- Positive control substance:
- other: daunomycine
- Remarks:
- described under test system conditions
- Details on test system and experimental conditions:
- Positive controls:
Without metabolic activation
Strain Chemical Solvent
TA1535 sodium azide (SA) (Fluka) 1 ug Saline
TA1537 9-aminoacridine (9AC) 60 ug Saline
(Janssen Chimical)
TA98 daunomycine (DM) (Sigma) 4 ug Saline
TA100 methylmethanesulfonate (MMS) 650 ug DMSO
(Merck)
With metabolic activation
Strain Chemical Sol vent
TA1535 and
TA1537 2-aminoanthracene (2AA) 5 ug DMSO
(Sigma)
TA 98 and
TA100 2-aminoanthracene (2AA) 0.5ug DMSO
(Sigma)
Solvents for reference substances:
Saline = physiological saline (Medital Pharma Ned. B. V.)
DMSO = dimethylsulphoxide of spectroscopic quality (Merck) - Evaluation criteria:
- ACCEPTABILITY OF ASSAY
A Sal monel l a typhimurium reverse mutation assay is considered acceptabl e if it meets the fol l owing criteria:
a) The negative control data (number of spontaneous revertants per plate) should reasonably be within the laboratory background historical range
for each tester strain.
b) The positive control chemicals should produce responses in all tester strains which also are reasonabl y within the laboratory historical range documented for each positive control substance. Furthermore, the mean plate count should be at least 2 times the concurrent vehicle control group mean
c) The sel ected dose range shoul d include a cl earl y toxic concentration as demonstrated by the prel iminary range-finding test with strain
TAI00 or shoul d extend to 5 mg/pl ate.
DATA EVALUATION AND STATISTICAL PROCEDURES
No formal hypothesis testing was done.
A test substance is considered negative (not mutagenic) in the test if:
a) The total number of revertants in any tester strain at any concentration is not greater than two times the sol vent control val ue, with or
without metabol ic activation.
b) The negative response shoul d be reproducibl e in at l east one independentl y repeated experiment.
A test substance is considered positive (mutagenic) in the test if:
a) It induces at l east a 2-fol d, dose rel ated increase in the number of revertants with respect to the number induced by the solvent control in
any of the tester strains, either with or without metabol ic activation. However, any mean pl ate count of l ess than 20 is considered to be not
significant. If in the first test the test substance shows only a positive response at one or two concentrations, the assay was repeated
with doses just below and exceeding those showing positive effects in the first test.
b) Positive response should be reproducible in at l east one independentl y repeated expt. The preceding criteria were not absolute and other modifying factors might enter into the final decision.
Results and discussion
Test results
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS
SELECTION OF DOSE LEVELS: HEOX-CN was tested in strain TA100 with concentrations of 3, 10, 33, 100, 333, 1000, 3330 and 5000 g/plate in the absence and presence of S9-mix. This prel iminary test is reported as a part of the first experiment of the mutation test (Tabl e 1) . The individual data are presented in Appendix 2 of the report.
Precipitate
HEOX-CN did not precipitate in the top agar. Precipitation of HEOX-CN on the pl ates was not observed at the start or at the end of the incubation period in tester strain TA100.
Toxicity
No reduction of the bacterial background l awn and no decrease in the number of revertants was observed.
Based on these data, HEOX-CN was tested in the mutation assay up to and including a concentration of 5000 g/pl ate in the absence and presence of S9-mix.
MUTATION ASSAY
Tables 1 and 2 show the results of the Sal monella typhimurium reverse mutation assay with HEOX-CN. The individual data are presented in Appendix 2 of the report.
Precipitate
HEOX-CN did not precipitate in the top agar. Precipitation of HEOX-CN on the pl ates was not observed at the start or at
the end of the incubation period in al l tester strains.
Toxicity of the test substance
The bacterial background l awn was not reduced at al l concentrations tested and no decrease in the number of revertants was observed.
Number of revertants
All bacterial strains showed negative responses over the entire dose range, i. e. no dose-related, two-fold, increase in the number of revertants in two
independentl y repeated experiments. The negative and strain-specific positive control values were within our laboratory background historical ranges indicating that the test conditions were adequate and that the metabolic activation system functioned properly. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
REFERENCES
1) Ames, B. N. , McCann, J. and Yamasaki, E., 1975, Methods for detecting carcinogens and mutagens with the Salmonella / mammalian microsome mutagenicity test, Mutation Res. , 31, 347 -364.
2) Maron, D. M. and Ames, B. N. , 1983, Revised methods for the Sal monel la mutagenicity test, Mutation Res. , 113, 173-215. Erratum, 1983, Mutation Res. , 113, 533.
3) Vogel , H. J. and Bonner, D. M. , 1956, Acetyl ornithinase of Escherichia coli: partial purification and some properties. J. Biol . Chem. , 218, 97-106.
Applicant's summary and conclusion
- Conclusions:
- Based on the resul ts of this study it is concl uded that HEOX-CN is not mutagenic in the Sal monella typhimurium reverse mutation assay.
- Executive summary:
The study procedures described in this report were based on the OECD Guideline no. 471: 'Genetic Toxicol ogy: Salmonella typhimurium Reverse Mutation Assay', (adopted May 26, 1983) and the EEC, Directive 92/69/EEC. Annex V of the EEC Directive 67/548/EEC, Part B: Methods for the Determination of Toxicity; B.14: 'Other Effects- Mutagenicity: Salmonel l a typhimurium - Reverse Mutation Assay'. December, 1992. The objective was to evaluate the test substance for its ability to induce reverse mutations in a gene of histidine- requiring Salmonella typhimurium bacterial strains to produce histidine - independent strains of these micro - organisms. JThis test system has been shown to be a rapid and adequate indicator for the mutagenic activity of a wide range of chemical compounds. The assay was conducted in the absence and in the presence of a metabolic system (S9 -mix) . Test strains used in this study were: TA98, TAI00, TA1535 and TA1537. The strains TA98 and TA1537 are capable of detecting frameshift mutagens; and strains TAI00 and TA1535 are capable of detecting base-pair substitution mutagens.
HEOX-CN (CAS# 2359 -11 -7) was tested in the Salmonella typhimurium reverse mutation assay with four histidine - requiring strains of Salmonella typhimurium (TA1535, TA1537, TA100 and TA98) in two independent experiments. HEOX-CN was tested up to and including concentrations of 5000 ug/plate in the absence and presence of S9 -mix. HEOX-CN did not induce a dose-related increase in the number of revertant colonies in the absence or in the presence of S9 - mix, in two independentl y repeated experiments.
Based on the results of this study it is concluded that HEOX-CN is not mutagenic in the Salmonell a typhimurium reverse mutation assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.